Secondary Logo

Journal Logo

Advanced Search

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid
Review Articles

Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute–Designated Cancer Centers

Prindiville, Sheila A. MD, MPH∗; Sarosy, Gisele A. MD∗; Loose, David BA†; Ciolino, Henry PhD‡; Doroshow, James H. MD§

Author Information

From the ∗Coordinating Center for Clinical Trials, Office of the Director, National Cancer Institute, National Institutes of Health, Bethesda

†Information Technology Manager, Essex Management, LLC, Rockville

‡Office of Cancer Centers

§Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Conflicts of Interest and Source of Funding: The data analyses have been supported by the National Cancer Institute, National Institutes of Health, under contract 140D0420F0417. The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

The authors are responsible for the content of this article, which does not necessarily represent the views of the National Academies of Sciences, Engineering, and Medicine.

Reprints: Sheila A. Prindiville, MD, MPH, Coordinating Center for Clinical Trials, National Cancer Institute, 9609 Medical Center Dr, Room 6W136, Bethesda, MD 20892. E-mail: [email protected].

doi: 10.1097/PPO.0000000000000578
  • Buy

Abstract

Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.